Key facts
- This page summarizes Life Science Biosensor Diagnostics Pty Ltd's Form 4 filing for GBS Inc. (INBS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Feb 2022, 17:14.
Life Science Biosensor Diagnostics Pty Ltd - 17 Feb 2022 Form 4 Insider Report for GBS Inc. (INBS)
- Reporting relationship
- Former 10% owner
- Issuer ticker
- INBS
- Reported as of
- 17 Feb 2022
- Net transaction value
- -$293,774
- SEC form
- 4
- Accepted by SEC
- 22 Feb 2022, 17:14:20 UTC
- Prior SEC filing
- 18 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ George Syrmalis
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Life Science Biosensor Diagnostics Pty Ltd filed Form 4 for GBS Inc. (INBS) on 22 Feb 2022.
Change
- Previous filing in this sequence was filed on 18 Feb 2022.
- Current net transaction value: -$293,774.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INBS
transaction
Common Stock
Sale
- Transaction value
- $293,774
- Shares
- -576,028
- Change %
- -35%
- Price
- $0.5100
- Shares after
- 1,081,804
- Date
- 17 Feb 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.